CClinicalTrials.gg
Sign In
CompletedNCT04912804PRO-COVIDUpdated Apr 15, 2022

Perceived Health After Hospitalization for COVID-19

An observational study in COVID-19, Post-hospitalization, Disease Impact, sponsored by Centre Hospitalier Universitaire Dijon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-15.

Sponsored by Centre Hospitalier Universitaire Dijon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
207
Ages
18 Years and older
Sex
All
01

Study summary

There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks

02

Conditions studied

  • COVID-19, Post-hospitalization, Disease Impact

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 207 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Centre Hospitalier Universitaire Dijon is the lead sponsor of 495 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient with COVID-19 discharged from a conventional short-stay hospital ward.

Inclusion criteria

  • Adult patient
  • Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan
  • Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection
  • Patient providing oral consent to participate in the study
  • Patient able to understand and answer the questionnaires used
  • Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS
  • Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship, curatorship or a measure of judicial safeguard
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
207 participants (actual)
Patient registry
No

Groups and cohorts

  • COVID-19 Patient

    Patient discharged from a conventional short-stay hospitalization unit.

    Other: Questionnaires

Interventions

  • OtherQuestionnaires

    SF-12, GHQ-12 and HAQ

06

What researchers measure

Primary outcomes

  1. Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 disease

    Time frame: Through study completion, an average of 6 months

  2. The value of perceived health scores in patients who achieved PASS and MCII

    Time frame: Through study completion, an average of 6 months

07

Study locations

1 site
  • Chu Dijon Bourogne
    Dijon, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04912804
Lead sponsor
Centre Hospitalier Universitaire Dijon
Responsible party
Sponsor
First posted
Jun 3, 2021
Start date
Jun 30, 2020
Primary completion
May 22, 2021
Completion
May 22, 2021
Last update
Apr 15, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19→

Other studies from this sponsor

Centre Hospitalier Universitaire Dijon

Start the discussion